Loading stock data…
Loading stock data…
US$31.56
Get one email when SEPN crosses your level. Checked every 15 minutes during market hours.
▼ -2.51 (-7.37%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
Healthcare · Biotechnology
Septerna Inc. is a clinical-stage biotechnology company specializing in the discovery and development of oral small molecule therapies targeting G protein-coupled receptors (GPCRs). Powered by its proprietary Native Complex Platform, the company unlocks challenging GPCR targets to create novel medicines for patients with significant unmet needs. Its wholly-owned pipeline focuses on three key therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Notable programs i…
septerna.com5 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (16 analysts, 2026-07-01)
4 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (15 analysts, 2026-06-01)
3 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (14 analysts, 2026-05-01)
3 strong buy · 10 buy · 1 hold · 0 sell · 0 strong sell (14 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-06-15 | 0.13 | 0.15 | ✓ Beat |
| 2026-05-11 | -0.44 | -0.19 | ✓ Beat |
| 2026-04-21 | 1.52 | 2.16 | ✓ Beat |
| 2026-03-19 | 0.16 | 0.17 | ✓ Beat |
| 2026-03-09 | -0.22 | -0.24 | ✗ Miss |
| 2026-02-03 | 3.32 | 3.33 | ✓ Beat |
| 2025-11-10 | 0.79 | -0.1 | ✗ Miss |
Companies in the same industry, via Finnhub
RSI (14-day)
42.8
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.55
Bearish momentumMACD below its signal line (1.14).
50-day average
31.44
Price aboveShort-term trend reference.
200-day average
26.55
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice